A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma

The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose.

What is lymphedema, what causes it and how can it be treated? Michigan Medicine lymphedema experts explain the condition and what treatments are available.

HPV circulating tumor DNA and MRI/PET imaging markers predicted which tumors would respond to chemoradiation as early as two weeks into treatment.

Blood transfusions were the only thing that helped Connor Burke cope with the fatigue of his chemotherapy. Now, amid a national blood shortage, he’s encouraging more people to donate blood

A multi-center study found that breast cancer patients experienced less pain and skin irritation when a more complex form of treatment planning was used for radiation. 

New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.

The algorithm FARDEEP offers a personalized approach to identify patients who better respond to regenerative therapies.

In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.

Researchers have found a common mutation in gliomas makes them sensitive to immunotherapy. Studies of mouse models indicate a potential path toward more effective treatments for this type of cancer.

Two studies highlight the important role of PCPs and their communication with patients at various stages of their cancer journeys.

The device, which takes measurements every two minutes, was able to detect infection and cytokine release syndrome events several hours sooner than routine monitoring.

Cell culture study maps mechanisms underlying a new potential strategy for killing pancreatic cancer cells through a type of cell death known as ferroptosis.

An analysis of patient data from across Michigan found scores from the Decipher Biopsy test independently aligned with outcomes.

Duke, who was profiled in March 2020, reflects on navigating life with stage 4 cancer while much of the country is focused on getting ‘back to normal’